Discontinuation report ALIMTA

Last updated on 2021-09-18 History
Report ID 136207
Drug Identification Number 02253437
Brand name ALIMTA
Common or Proper name PEMETREXED DISODIUM FOR INJECTION
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) PEMETREXED
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 500mg /50mL vial
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-09-17
Actual discontinuation date 2021-09-17
Remaining supply date 2021-09-17
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply ALIMTA® 500mg /50mL (DIN 02253437) has been discontinued. The ALIMTA 100mg /10mL vial (DIN 02306433) remains available.
Company comments Please contact Eli Lilly Canada's Response Centre 1-888-545-5972 should you have any questions.
Health Canada comments
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-09-18 English Compare
v8 2021-09-17 French Compare
v7 2021-09-17 English Compare
v6 2021-09-17 English Compare
v5 2021-09-01 French Compare
v4 2021-09-01 English Compare
v3 2021-03-24 French Compare
v2 2021-03-24 English Compare
v1 2021-03-24 English Compare